30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Neumora Therapeutics Inc (NMRA)

Track

The most recent insider trading activity occurred on February 17, 2026, with multiple officers and the President engaging in proposed and actual sales. Prior to this, significant buy transactions were noted on October 27, 2025, by ARCH Venture Partners and Kristina Burow. The last reported earnings were on May 12, 2026.
Stock chart
Ticker: NMRA Exchange: NSM
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Aurora Daljit Singh
See Remarks
2 sales — total 43,833 USD
Sale 17 Feb 2026
Value US$433,187.22 | Price 233.64 | Shares 18,276
Proposed sale 17 Feb 2026
Value US$3,106,517.21 | Price 470.90 | Shares 74,532
Sale 17 Feb 2026
Value US$3,667,872.11 | Price 184.82 | Shares 57,257
Proposed sale 17 Feb 2026
Value US$1,539,549.29 | Price 196.23 | Shares 8,006
Sale 17 Feb 2026
Value US$34,458.80 | Price 3.51 | Shares 9,819
Proposed sale 17 Feb 2026
Value US$34,458.98 | Price 3.51 | Shares 9,819
Planned sale 17 Feb 2026
Value US$5,119.34 | Price 3.57 | Shares 1,436
Proposed sale 17 Feb 2026
Value US$5,119.34 | Price 3.57 | Shares 1,436
Planned sale 11 Nov 2025
Value US$307,025.52 | Price 2.68 | Shares 114,703
Proposed sale 11 Nov 2025
Value US$307,027.47 | Price 2.68 | Shares 114,703
Buy 27 Oct 2025
Value US$4,999,977.00 | Price 2.61 | Shares 1,915,700
Buy 27 Oct 2025
Value US$4,999,977.00 | Price 2.61 | Shares 1,915,700
Buy 27 Oct 2025
Value US$4,999,977.00 | Price 2.61 | Shares 1,915,700
Proposed sale 12 Mar 2025
Value US$21,450.00 | Price 1.43 | Shares 15,000
Planned sale 18 Feb 2025
Value US$23,468.34 | Price 1.69 | Shares 13,871
Proposed sale 18 Feb 2025
Value US$23,468.27 | Price 1.69 | Shares 13,871
Planned sale 18 Feb 2025
Value US$14,347.23 | Price 1.68 | Shares 8,565
Proposed sale 18 Feb 2025
Value US$14,347.50 | Price 1.68 | Shares 8,565
Planned sale 18 Feb 2025
Value US$13,477.18 | Price 1.67 | Shares 8,048
Proposed sale 18 Feb 2025
Value US$13,477.57 | Price 1.67 | Shares 8,048
Planned sale 18 Feb 2025
Value US$3,350.53 | Price 1.69 | Shares 1,978
Proposed sale 18 Feb 2025
Value US$3,350.53 | Price 1.69 | Shares 1,978
Planned sale 18 Feb 2025
Value US$9,383.24 | Price 1.67 | Shares 5,614
Proposed sale 18 Feb 2025
Value US$9,383.49 | Price 1.67 | Shares 5,614
Proposed sale 18 Feb 2025
Value US$16,020.12 | Price 1.68 | Shares 9,540
Proposed sale 18 Feb 2025
Value US$11,461.84 | Price 1.67 | Shares 6,857
Proposed sale 18 Oct 2024
Value US$239,318.98 | Price 17.03 | Shares 14,049
Planned sale 18 Oct 2024
Value US$239,319.10 | Price 17.03 | Shares 14,049
Planned sale 17 Oct 2024
Value US$131,642.71 | Price 17.01 | Shares 7,739
Proposed sale 17 Oct 2024
Value US$131,642.77 | Price 17.01 | Shares 7,739
Planned sale 10 Oct 2024
Value US$124,602.93 | Price 15.09 | Shares 8,260
Proposed sale 10 Oct 2024
Value US$124,602.57 | Price 15.09 | Shares 8,260
Planned sale 9 Oct 2024
Value US$83,507.31 | Price 15.01 | Shares 5,563
Proposed sale 9 Oct 2024
Value US$83,507.08 | Price 15.01 | Shares 5,563
Planned sale 18 Sep 2024
Value US$129,090.99 | Price 12.09 | Shares 10,676
Proposed sale 18 Sep 2024
Value US$129,090.97 | Price 12.09 | Shares 10,676
Planned sale 17 Sep 2024
Value US$363,735.59 | Price 11.81 | Shares 30,788
Proposed sale 17 Sep 2024
Value US$363,734.12 | Price 11.81 | Shares 30,788
Planned sale 12 Sep 2024
Value US$376,664.83 | Price 11.43 | Shares 32,948
Proposed sale 12 Sep 2024
Value US$376,664.61 | Price 11.43 | Shares 32,948
Planned sale 27 Aug 2024
Value US$178,806.04 | Price 11.39 | Shares 15,693
Planned sale 26 Aug 2024
Value US$372,587.71 | Price 11.78 | Shares 31,642
Planned sale 23 Aug 2024
Value US$280,005.12 | Price 11.59 | Shares 24,169
Planned sale 22 Aug 2024
Value US$331,468.32 | Price 11.63 | Shares 28,496
Proposed sale 22 Aug 2024
Value US$1,190,000.00 | Price 11.90 | Shares 100,000
Buy 14 Nov 2023
Value US$40,216.86 | Price 11.98 | Shares 3,357
Buy 14 Nov 2023
Value US$40,216.86 | Price 11.98 | Shares 3,357
Buy 13 Nov 2023
Value US$371,922.75 | Price 11.75 | Shares 31,653
Buy 13 Nov 2023
Value US$371,922.75 | Price 11.75 | Shares 31,653
Buy 10 Nov 2023
Value US$63,814.25 | Price 11.75 | Shares 5,431
Buy 10 Nov 2023
Value US$134,666.28 | Price 11.37 | Shares 11,844
Buy 10 Nov 2023
Value US$63,814.25 | Price 11.75 | Shares 5,431
Buy 10 Nov 2023
Value US$134,666.28 | Price 11.37 | Shares 11,844
Buy 9 Nov 2023
Value US$327,261.87 | Price 10.53 | Shares 31,079
Buy 9 Nov 2023
Value US$327,261.87 | Price 10.53 | Shares 31,079
Buy 8 Nov 2023
Value US$272,631.96 | Price 11.79 | Shares 23,124
Buy 8 Nov 2023
Value US$745,189.06 | Price 10.78 | Shares 69,127
Buy 8 Nov 2023
Value US$272,631.96 | Price 11.79 | Shares 23,124
Buy 8 Nov 2023
Value US$745,189.06 | Price 10.78 | Shares 69,127
Buy 7 Nov 2023
Value US$347,208.00 | Price 11.50 | Shares 30,192
Buy 7 Nov 2023
Value US$347,208.00 | Price 11.50 | Shares 30,192
Buy 6 Nov 2023
Value US$497,597.10 | Price 11.55 | Shares 43,082
Buy 6 Nov 2023
Value US$497,597.10 | Price 11.55 | Shares 43,082
Buy 3 Nov 2023
Value US$255,139.60 | Price 11.38 | Shares 22,420
Buy 3 Nov 2023
Value US$255,139.60 | Price 11.38 | Shares 22,420
Buy 29 Sep 2023
Value US$483,148.80 | Price 13.98 | Shares 34,560
Buy 29 Sep 2023
Value US$483,148.80 | Price 13.98 | Shares 34,560
Buy 28 Sep 2023
Value US$343,755.90 | Price 13.69 | Shares 25,110
Buy 28 Sep 2023
Value US$219,943.46 | Price 13.06 | Shares 16,841
Buy 28 Sep 2023
Value US$343,755.90 | Price 13.69 | Shares 25,110
Buy 28 Sep 2023
Value US$219,943.46 | Price 13.06 | Shares 16,841
Buy 27 Sep 2023
Value US$301,644.24 | Price 12.31 | Shares 24,504
Buy 27 Sep 2023
Value US$301,644.24 | Price 12.31 | Shares 24,504
Buy 26 Sep 2023
Value US$398,820.00 | Price 11.73 | Shares 34,000
Buy 26 Sep 2023
Value US$398,820.00 | Price 11.73 | Shares 34,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-02-19 2026-02-17 S Sale
Aurora Daljit Singh

See Remarks

Officer
18,276 +32.8%
233.64
US$433,187 		18,276 +32.8% 233.64 US$433,187
2026-02-19 2026-02-17 S Sale
Pinto Joshua

President

Officer
57,257 -10.3%
184.82
US$3,667,872 		57,257 -10.3% 184.82 US$3,667,872
2026-02-19 2026-02-17 S Sale
1.5
BERNS PAUL L

See Remarks

Executive Director
93,669 +8.9%
242.29
US$4,900,695 		93,669 +8.9% 242.29 US$4,900,695
2026-02-19 2026-02-17 PlS Planned sale
Milligan Michael Lee

See Remarks

Officer
1,436 -6.4%
3.57
US$5,119 		1,436 -6.4% 3.57 US$5,119
2026-02-17 2026-02-17 PrS Proposed sale
Milligan Michael Lee

Officer

Officer
1,436
3.57
US$5,119 		1,436 3.57 US$5,119
2026-02-17 2026-02-17 PrS Proposed sale
Pinto Joshua

Officer

Officer
5,967
3.54
US$21,093 		5,967 3.54 US$21,093
2026-02-17 2026-02-17 PrS Proposed sale
Aurora Daljit Singh

Officer

Officer
6,165
3.56
US$21,917 		6,165 3.56 US$21,917
2026-02-17 2026-02-17 PrS Proposed sale
1.5
BERNS PAUL L

Officer

Officer
9,819
3.51
US$34,459 		9,819 3.51 US$34,459
2025-11-13 2025-11-11 PlS Planned sale
Aurora Daljit Singh

See Remarks

Officer
114,703 -100.0%
2.68
US$307,026 		114,703 -100.0% 2.68 US$307,026
2025-11-12 2025-11-11 PrS Proposed sale
Aurora Family Trust

Director; Officer

Executive Director
114,703
2.68
US$307,027 		114,703 2.68 US$307,027
2025-10-29 2025-10-27 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
1,915,700 +46.4%
2.61
US$4,999,977 		1,915,700 +46.4% 2.61 US$4,999,977
2025-10-29 2025-10-27 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
1,915,700 +46.4%
2.61
US$4,999,977 		1,915,700 +46.4% 2.61 US$4,999,977
2025-10-29 2025-10-27 B Purchase
3.4
ARCH Venture Partners X, LLC
Large shareholder
1,915,700 +46.4%
2.61
US$4,999,977 		1,915,700 +46.4% 2.61 US$4,999,977
2025-03-12 2025-03-12 PrS Proposed sale
3.2
Henry Gosebruch

Officer; Director

Executive Director
15,000
1.43
US$21,450 		15,000 1.43 US$21,450
2025-02-20 2025-02-18 PlS Planned sale
1.5
BERNS PAUL L

See Remarks

Executive Director
13,871 -0.2%
1.69
US$23,468 		13,871 -0.2% 1.69 US$23,468
2025-02-20 2025-02-18 PlS Planned sale
Aurora Daljit Singh

Chief Strategy Officer

Officer
8,565 -8.8%
1.68
US$14,347 		8,565 -8.8% 1.68 US$14,347
2025-02-20 2025-02-18 PlS Planned sale
Pinto Joshua

President

Officer
8,048 -9.5%
1.67
US$13,477 		8,048 -9.5% 1.67 US$13,477
2025-02-20 2025-02-18 PlS Planned sale
Milligan Michael Lee

See Remarks

Officer
1,978 -8.1%
1.69
US$3,351 		1,978 -8.1% 1.69 US$3,351
2025-02-20 2025-02-18 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
5,614 -1.8%
1.67
US$9,383 		5,614 -1.8% 1.67 US$9,383
2025-02-18 2025-02-18 PrS Proposed sale
Suh Carol Y.

Officer

Officer
9,540
1.68
US$16,020 		9,540 1.68 US$16,020
2025-02-18 2025-02-18 PrS Proposed sale
Milligan Michael Lee

Officer

Officer
1,978
1.69
US$3,351 		1,978 1.69 US$3,351
2025-02-18 2025-02-18 PrS Proposed sale
Pinto Joshua

Officer

Officer
8,048
1.67
US$13,478 		8,048 1.67 US$13,478
2025-02-18 2025-02-18 PrS Proposed sale
Lenz Robert A.

Officer

Officer
5,614
1.67
US$9,383 		5,614 1.67 US$9,383
2025-02-18 2025-02-18 PrS Proposed sale
3.2
Gosebruch Henry O

Officer; Director

Executive Director
6,857
1.67
US$11,462 		6,857 1.67 US$11,462
2025-02-18 2025-02-18 PrS Proposed sale
1.5
BERNS PAUL L

Officer

Officer
13,871
1.69
US$23,468 		13,871 1.69 US$23,468
2025-02-18 2025-02-18 PrS Proposed sale
Aurora Daljit Singh

Officer

Officer
8,565
1.68
US$14,348 		8,565 1.68 US$14,348
2024-10-18 2024-10-18 PrS Proposed sale
3.8
Fust Matthew K

Director

Non-Executive Director
14,049
17.03
US$239,319 		14,049 17.03 US$239,319
2024-10-18 2024-10-18 PlS Planned sale
3.8
Fust Matthew K
Non-Executive Director
14,049 -41.1%
17.03
US$239,319 		14,049 -41.1% 17.03 US$239,319
2024-10-18 2024-10-17 PlS Planned sale
3.8
Fust Matthew K
Non-Executive Director
7,739 -27.8%
17.01
US$131,643 		7,739 -27.8% 17.01 US$131,643
2024-10-17 2024-10-17 PrS Proposed sale
3.8
Fust Matthew K

Director

Non-Executive Director
7,739
17.01
US$131,643 		7,739 17.01 US$131,643
2024-10-11 2024-10-10 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
8,260 -2.6%
15.09
US$124,603 		8,260 -2.6% 15.09 US$124,603
2024-10-10 2024-10-10 PrS Proposed sale
Lenz Robert A.

Officer

Officer
8,260
15.09
US$124,603 		8,260 15.09 US$124,603
2024-10-11 2024-10-09 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
5,563 -1.7%
15.01
US$83,507 		5,563 -1.7% 15.01 US$83,507
2024-10-09 2024-10-09 PrS Proposed sale
Lenz Robert A.

Officer

Officer
5,563
15.01
US$83,507 		5,563 15.01 US$83,507
2024-09-19 2024-09-18 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
10,676 -3.1%
12.09
US$129,091 		10,676 -3.1% 12.09 US$129,091
2024-09-18 2024-09-18 PrS Proposed sale
Lenz Robert A.

Officer

Officer
10,676
12.09
US$129,091 		10,676 12.09 US$129,091
2024-09-19 2024-09-17 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
30,788 -8.3%
11.81
US$363,736 		30,788 -8.3% 11.81 US$363,736
2024-09-17 2024-09-17 PrS Proposed sale
Lenz Robert A.

Officer

Officer
30,788
11.81
US$363,734 		30,788 11.81 US$363,734
2024-09-16 2024-09-12 PlS Planned sale
Lenz Robert A.

Head of R&D

Officer
32,948 -8.2%
11.43
US$376,665 		32,948 -8.2% 11.43 US$376,665
2024-09-12 2024-09-12 PrS Proposed sale
Lenz Robert A.

Officer

Officer
32,948
11.43
US$376,665 		32,948 11.43 US$376,665
2024-08-27 2024-08-27 PlS Planned sale
Pinto Joshua

Chief Financial Officer

Officer
15,693 -10.1%
11.39
US$178,806 		15,693 -10.1% 11.39 US$178,806
2024-08-26 2024-08-26 PlS Planned sale
Pinto Joshua

Chief Financial Officer

Officer
31,642 -17.0%
11.78
US$372,588 		31,642 -17.0% 11.78 US$372,588
2024-08-26 2024-08-23 PlS Planned sale
Pinto Joshua

Chief Financial Officer

Officer
24,169 -11.5%
11.59
US$280,005 		24,169 -11.5% 11.59 US$280,005
2024-08-26 2024-08-22 PlS Planned sale
Pinto Joshua

Chief Financial Officer

Officer
28,496 -11.9%
11.63
US$331,468 		28,496 -11.9% 11.63 US$331,468
2024-08-22 2024-08-22 PrS Proposed sale
Pinto Joshua

Officer

Officer
100,000
11.90
US$1,190,000 		100,000 11.90 US$1,190,000
2023-11-15 2023-11-14 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
3,357 +0.1%
11.98
US$40,217 		3,357 +0.1% 11.98 US$40,217
2023-11-15 2023-11-14 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
3,357 +0.1%
11.98
US$40,217 		3,357 +0.1% 11.98 US$40,217
2023-11-15 2023-11-13 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
31,653 +0.8%
11.75
US$371,923 		31,653 +0.8% 11.75 US$371,923
2023-11-15 2023-11-13 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
31,653 +0.8%
11.75
US$371,923 		31,653 +0.8% 11.75 US$371,923
2023-11-13 2023-11-10 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
5,431 +0.1%
11.75
US$63,814 		5,431 +0.1% 11.75 US$63,814
2023-11-13 2023-11-10 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
11,844 +0.3%
11.37
US$134,666 		11,844 +0.3% 11.37 US$134,666
2023-11-13 2023-11-10 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
5,431 +0.1%
11.75
US$63,814 		5,431 +0.1% 11.75 US$63,814
2023-11-13 2023-11-10 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
11,844 +0.3%
11.37
US$134,666 		11,844 +0.3% 11.37 US$134,666
2023-11-13 2023-11-09 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
31,079 +0.8%
10.53
US$327,262 		31,079 +0.8% 10.53 US$327,262
2023-11-13 2023-11-09 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
31,079 +0.8%
10.53
US$327,262 		31,079 +0.8% 10.53 US$327,262
2023-11-13 2023-11-08 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
23,124 +0.6%
11.79
US$272,632 		23,124 +0.6% 11.79 US$272,632
2023-11-13 2023-11-08 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
69,127 +1.7%
10.78
US$745,189 		69,127 +1.7% 10.78 US$745,189
2023-11-13 2023-11-08 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
23,124 +0.6%
11.79
US$272,632 		23,124 +0.6% 11.79 US$272,632
2023-11-13 2023-11-08 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
69,127 +1.7%
10.78
US$745,189 		69,127 +1.7% 10.78 US$745,189
2023-11-07 2023-11-07 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
30,192 +0.8%
11.50
US$347,208 		30,192 +0.8% 11.50 US$347,208
2023-11-07 2023-11-07 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
30,192 +0.8%
11.50
US$347,208 		30,192 +0.8% 11.50 US$347,208
2023-11-07 2023-11-06 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
43,082 +1.1%
11.55
US$497,597 		43,082 +1.1% 11.55 US$497,597
2023-11-07 2023-11-06 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
43,082 +1.1%
11.55
US$497,597 		43,082 +1.1% 11.55 US$497,597
2023-11-07 2023-11-03 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
22,420 +0.6%
11.38
US$255,140 		22,420 +0.6% 11.38 US$255,140
2023-11-07 2023-11-03 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
22,420 +0.6%
11.38
US$255,140 		22,420 +0.6% 11.38 US$255,140
2023-09-29 2023-09-29 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
34,560 +0.9%
13.98
US$483,149 		34,560 +0.9% 13.98 US$483,149
2023-09-29 2023-09-29 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
34,560 +0.9%
13.98
US$483,149 		34,560 +0.9% 13.98 US$483,149
2023-09-29 2023-09-28 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
25,110 +0.7%
13.69
US$343,756 		25,110 +0.7% 13.69 US$343,756
2023-09-29 2023-09-28 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
16,841 +0.4%
13.06
US$219,943 		16,841 +0.4% 13.06 US$219,943
2023-09-29 2023-09-28 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
25,110 +0.7%
13.69
US$343,756 		25,110 +0.7% 13.69 US$343,756
2023-09-29 2023-09-28 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
16,841 +0.4%
13.06
US$219,943 		16,841 +0.4% 13.06 US$219,943
2023-09-27 2023-09-27 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
24,504 +0.7%
12.31
US$301,644 		24,504 +0.7% 12.31 US$301,644
2023-09-27 2023-09-27 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
24,504 +0.7%
12.31
US$301,644 		24,504 +0.7% 12.31 US$301,644
2023-09-27 2023-09-26 B Purchase
3.2
Burow Kristina
Non-Executive Director Large shareholder
34,000 +0.9%
11.73
US$398,820 		34,000 +0.9% 11.73 US$398,820
2023-09-27 2023-09-26 B Purchase
3.6
ARCH Venture Partners XII, LLC
Large shareholder
34,000 +0.9%
11.73
US$398,820 		34,000 +0.9% 11.73 US$398,820
Explore more

More insider trading research around Neumora Therapeutics Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America